Results 11 to 20 of about 582,366 (292)
Stem Cell Research, 2021 Recently, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has spread around the world and is receiving worldwide attention. Approximately 20% of infected patients are suffering from severe disease of multiple systems and in danger of death, while the ocular complications of SARS-CoV-2-infected patients have not been reported generally. Herein,
Li, Yan-Ping +3 more
openaire +3 more sources
Ambiociencias, 2021 Las enfermedades causadas por coronavirus son conocidas y han sido estudiadas en veterinaria muchos años antes que en medicina humana por su importancia y por sus efectos en distintas especies de aves y de mamíferos. La primera vacunacontra una enfermedad por coronavirus en animales, la bronquitis infecciosa aviar, se desarrolló en 1950 mientras que el
Rubio Nistal, Pedro Miguel +1 more
openaire +6 more sources
Vaccine trials during a pandemic: potential approaches to ethical dilemmas
Trials, 2021 Ever since the emergence of the coronavirus disease 2019 (COVID-19), global public health infrastructures and systems, along with community-wide collaboration and service, have risen to an unprecedented challenge.
Manaf Alqahtani +3 more
doaj +1 more source
Population and Economics, 2020 In the previous decade, the Russian tourism industry has shown steady development. But in 2020, due to the consequences of the COVID-19 pandemic, the situation is close to disaster. It is necessary to provide not only urgent support for industry actors but also the conditions for the successful resumption of their activities in the long term.
openaire +3 more sources
Vaccines, 2021 Background: Mucormycosis is a life-threatening invasive fungal infection most commonly observed in immunocompromised patients. Throughout the COVID-19 pandemic, a growing number of Mucorales associated infections, now termed COVID-19 associated ...
Elsa Yolanda Palou +13 more
doaj +1 more source
New Scientist, 2021 Several new viral variants pose added threats - how worried should we be?
openaire +3 more sources
Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3–12 Years Old
Vaccines, 2022 Background and Objectives: In the current COVID-19 pandemic, children below the age of 12 could manifest COVID-19 symptoms and serve as a reservoir for the virus in the community.
Khaled Greish +13 more
doaj +1 more source
Cell & Bioscience, 2022 Background Thrombosis and coagulopathy are pervasive pathological features of coronavirus disease 2019 (COVID-19), and thrombotic complications are a sign of severe COVID-19 disease and are associated with multiple organ failure and increased mortality ...
Weiping Ji +9 more
doaj +1 more source
New Scientist, 2021 UK efforts to track the virus's evolution and the emergence of new variants have been vital, Sharon Peacock tells Michael Le Page.
openaire +3 more sources